Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Call for panel nominations

This article was originally published in The Tan Sheet

Executive Summary

Nominations for voting consumer representatives on CDER advisory committees will be accepted until the end of the year, FDA says in an April 13 Federal Register notice. Spots on the Nonprescription Drugs, Metabolic & Endocrinologic Drugs, Arthritis Drugs, Pulmonary-Allergy Drugs, Cardiovascular & Renal Drugs and Anti-Infective Drugs are open. Nominations should include a cover letter, CV or resume, and list of community or consumer groups in which the candidate is involved; self nominations will be accepted, FDA notes...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098079

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel